| Company/Division name | Lilly and Company |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 700 |
| Year reshoring announced: | 2023 |
| Capital investment ($): | 1600 |
| City reshored to: | Indianapolis |
| State(s) reshored to: | IN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | medicines for diabetes and cancer, |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Impact on domestic economy, Lead time/Time to market, Skilled workforce availability/training, Under-utilized capacity |
